LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

SEVERE MYOCARDITIS AS A COMPLICATION OF A NOVEL DUAL IMMUNOTHERAPY TREATMENT IN A PATIENT WITH ESOPHAGEAL CANCER

Photo by nci from unsplash

Immunotherapy has been introduced into the treatment of numerous cancers with impressive survival benefits. However, several immune-related adverse events (irAEs) have been reported, including a spectrum of myocardial toxicities in… Click to show full abstract

Immunotherapy has been introduced into the treatment of numerous cancers with impressive survival benefits. However, several immune-related adverse events (irAEs) have been reported, including a spectrum of myocardial toxicities in 1-3% of patients, for which there is a need for increased awareness

Keywords: complication novel; immunotherapy; myocarditis complication; treatment; severe myocarditis; novel dual

Journal Title: Journal of the American College of Cardiology
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.